Momenta, Sandoz Sought Clot Drug Monopoly, Suit Says
Momenta Pharmaceuticals and Sandoz have been hit with a proposed antitrust class action by a Tennessee hospital alleging they conspired to monopolize the market for a generic version of the blood...To view the full article, register now.
Already a subscriber? Click here to view full article